Home / Intelligence / Analyst Reports / Everest Group recognizes Trinity Life Sciences as a Featured Specialist in Operationalizing Generative AI in Life Sciences
Everest Group report:
AI-deas to Action: Operationalizing Generative AI in Life Sciences
This research report provides a comprehensive analysis of how generative AI (GenAI) is being operationalized in the life sciences industry and assesses the capabilities of the fifteen vendors included.
The report highlights several of Trinity’s key strengths, including:
Life Sciences Industry Expertise
Trinity has nearly 30 years of experience in the industry, providing evidence-based solutions to over 300 clients, including the global top 20 biopharma companies. This deep expertise translates siloed information into meaningful and effective insights.
Collaboration Between AI Technology and Human Experts
By embedding expert-driven feedback loops, Trinity enhances the accuracy and relevance of AI outputs, creating a collaborative environment where AI technology and human insights work together to drive efficiency, innovation and strategic decision‑making.
GenAI Tailored for the Life Sciences
The Trinity approach integrates cutting-edge GenAI models with domain-specific data to optimize GenAI for specific life sciences functions.
Access the report
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Trinity Life Sciences’ generative AI strategy blends foundational AI models with deep life sciences expertise, focusing on high-quality data, targeted functional optimization, and an expert-driven feedback loop. Through a value chain segment-based approach, particularly rooted in the sales and marketing segment, the company is working to drive meaningful AI adoption.
—Aastha Malik, Practice Director at Everest Group
Related Intelligence
Blog
AI-driven Advancements in Life Sciences
The momentum behind AI-driven advancements in life sciences has never been stronger, and this trend was spotlighted in Everest Group’s new 2025 PEAK Matrix® report, “Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025.” Trinity Life Sciences is honored to be recognized as a Leader in this comprehensive assessment, a distinction rooted […]
Read More
Webinars
Making Segmentation Real with AI Webinar Series
September 30, 2025 | 1:00 PM ET & October 16, 2025 | 12:00 PM ET
“This is the gold standard approach to segmentation.” —Trinity Life Sciences’ client and repeat Weave user Life sciences companies often struggle with fragmented data, complex segmentation solutions, and difficulty translating analytical segments into actionable engagement strategies. Join us for a two-part webinar series showcasing two of Trinity’s AI-enabled solutions, Real Insights Weave and Auras, designed to […]
Sign Up Now
Webinars
Unlocking Medical Impact with AI
September 18, 2025 | 1:00 – 1:45 PM ET
Medical Affairs teams are under growing pressure to deliver faster insights, smarter engagement, and measurable value—yet many are limited by manual processes, fragmented data, and time-intensive workflows. Join us for the next webinar in our “AI Innovations in Life Sciences” series, where Trinity experts will show how it is possible with AI to unlock deeper, novel insights, power efficient workflows, and drive greater impact in the Medical Affairs field and headquarters functions.
Sign Up Now